Abstract:Enterovirus 71 (EV-A71) is a major cause of hand, foot, and mouth disease (HFMD). Infection with EV-A71 is more often associated with neurological complications in children and is responsible for the majority of fatalities, but currently there is no approved antiviral therapy for treatment. Here, we identified auraptene, formononetin, and yangonin as effective inhibitors of EV-A71 infection in the low-micromolar range from screening of a natural product library. Among them, formononetin and yangonin selectively inhibited EV-A71 while auraptene could inhibit viruses within the enterovirus species A. Time of addition studies showed that all the three inhibitors inhibit both attachment and postattachment step of entry. We found mutations conferring the resistance to these inhibitors in the VP1 and VP4 capsid proteins and confirmed the target residues using a reverse genetic approach. Interestingly, auraptene- and formononetin-resistant viruses exhibit cross-resistance to other inhibitors while yangonin-resistant virus still remains susceptible to auraptene and formononetin. Moreover, auraptene and formononetin, but not yangonin protected EV-A71 against thermal inactivation, indicating a direct stabilizing effect of both compounds on virion capsid conformation. Finally, neither biochanin A (an analog of formononetin) nor DL-Kavain (an analog of yangonin) exhibited anti-EV-A71 activity, suggesting the structural elements required for anti-EV-A71 activity. Taken together, these compounds could become potential lead compounds for anti-EV-A71 drug development and also serve as tool compounds for studying virus entry.

Identification and Structure–Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors

Synthesis Of N-Benzyl-N-Phenylthiophene-2-Carboxamide Analogues As A Novel Class Of Enterovirus 71 Inhibitors

Identification of Dibucaine Derivatives As Novel Potent Enterovirus 2C Helicase Inhibitors: in Vitro, in Vivo, and Combination Therapy Study

Synthesis and Broad Antiviral Activity of Novel 2-Aryl-isoindolin-1-ones Towards Diverse Enterovirus A71 Clinical Isolates

Synthesis and Antiviral Activities of a Novel Class of Thioflavone and Flavonoid Analogues

Synthesis and Antiviral Activity of N-phenylbenzamide Derivatives, a Novel Class of Enterovirus 71 Inhibitors.

Characterization of Three Small Molecule Inhibitors of Enterovirus 71 Identified from Screening of a Library of Natural Products

Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein

Discovery of Aminothiazole Derivatives As Novel Human Enterovirus A71 Capsid Protein Inhibitors

Inhibition of Enterovirus 71 Replication by an Α-Hydroxy-nitrile Derivative NK-1.9k

Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors As Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.

New Potent EV-A71 Antivirals Targeting Capsid.

Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors as Therapeutic Drug Leads for the Treatment of Human Hand, Foot and Mouth Disease (HFMD).

Design, Synthesis, and Biological Evaluation of Anti-Ev71 Agents.

Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition

Cyanohydrin As An Anchoring Group For Potent And Selective Inhibitors Of Enterovirus 71 3c Protease

Antiviral Activities of Peptide-Based Covalent Inhibitors of the Enterovirus 71 3c Protease

Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71

Discovery and Optimization of Quinoline Analogues As Novel Potent Antivirals Against Enterovirus D68

Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71

Synthesis and Structure–activity Relationship of Α-Keto Amides As Enterovirus 71 3C Protease Inhibitors